{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:17:51Z","timestamp":1771006671497,"version":"3.50.1"},"reference-count":42,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.3892\/ijo.2015.3044","type":"journal-article","created":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T10:05:41Z","timestamp":1434017141000},"page":"592-600","source":"Crossref","is-referenced-by-count":11,"title":["Huachansu mediates cell death in non-Hodgkin\u2019s lymphoma by induction of caspase-3 and inhibition of MAP kinase"],"prefix":"10.3892","volume":"47","author":[{"given":"EKEM T.","family":"EFUET","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIAO-PING","family":"DING","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CARRIE","family":"CARTWRIGHT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YONG","family":"PAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LORENZO","family":"COHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PEIYING","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,6,11]]},"reference":[{"key":"key20180107190932_b1-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(03)13868-8","article-title":"Non-Hodgkin lymphoma","volume":"362","author":"Evans","year":"2003","journal-title":"Lancet"},{"key":"key20180107190932_b2-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1200\/JCO.2001.19.2.389","article-title":"Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin\u2019s lymphoma","volume":"19","author":"Vose","year":"2001","journal-title":"J Clin Oncol"},{"key":"key20180107190932_b3-ijo-47-02-0592","first-page":"11","article-title":"Mantle cell lymphoma: From pathology and molecular pathogenesis to new therapeutic perspectives","volume":"91","author":"Salaverria","year":"2006","journal-title":"Haematologica"},{"key":"key20180107190932_b4-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1158\/0008-5472.CAN-09-3578","article-title":"Responses in mantle cell lymphoma cells to SNS-032 depend on the biological context of each cell line","volume":"70","author":"Chen","year":"2010","journal-title":"Cancer Res"},{"key":"key20180107190932_b5-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.beha.2012.01.003","article-title":"New insights into the biology of molecular subtypes of diffuse large B-cell lymphoma and Burkitt lymphoma","volume":"25","author":"Frick","year":"2012","journal-title":"Best Pract Res Clin Haematol"},{"key":"key20180107190932_b6-ijo-47-02-0592","first-page":"717","article-title":"Apoptosis-inducing activity of compounds screened and characterized from cinobufacini by bioassay-guided isolation","volume":"3","author":"Wang","year":"2010","journal-title":"Mol Med Rep"},{"key":"key20180107190932_b7-ijo-47-02-0592","first-page":"2141","article-title":"Huachansu, containing cardiac glycosides, enhances radiosensitivity of human lung cancer cells","volume":"31","author":"Wang","year":"2011","journal-title":"Anticancer Res"},{"key":"key20180107190932_b8-ijo-47-02-0592","first-page":"93","article-title":"Anticancer potential of animal venoms and toxins","volume":"48","author":"Gomes","year":"2010","journal-title":"Indian J Exp Biol"},{"key":"key20180107190932_b9-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.intimp.2010.12.007","article-title":"Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor","volume":"11","author":"Qi","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"key20180107190932_b10-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.3748\/wjg.14.5210","article-title":"Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma","volume":"14","author":"Qin","year":"2008","journal-title":"World J Gastroenterol"},{"key":"key20180107190932_b11-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1002\/cncr.24602","article-title":"Pilot study of huachansu in patients with hepatocellular carcinoma, non-small-cell lung cancer, or pancreatic cancer","volume":"115","author":"Meng","year":"2009","journal-title":"Cancer"},{"key":"key20180107190932_b12-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.steroids.2005.12.003","article-title":"Cytotoxic biotransformed products from cinobufagin by Mucor spinosus and Aspergillus Niger","volume":"71","author":"He","year":"2006","journal-title":"Steroids"},{"key":"key20180107190932_b13-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/pros.10172","article-title":"Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells","volume":"54","author":"Yeh","year":"2003","journal-title":"Prostate"},{"key":"key20180107190932_b14-ijo-47-02-0592","first-page":"637","article-title":"Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells","volume":"21","author":"Takai","year":"2008","journal-title":"Int J Mol Med"},{"key":"key20180107190932_b15-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3181\/0811-RM-326","article-title":"Involvement of caspase-3 activity and survivin downregulation in cinobufocini-induced apoptosis in A 549 cells","volume":"234","author":"Wang","year":"2009","journal-title":"Exp Biol Med (Maywood)"},{"key":"key20180107190932_b16-ijo-47-02-0592","first-page":"341","article-title":"Cinobufacini induces the apoptosis of U937 cells and its mechanism","volume":"27","author":"Zhang","year":"2007","journal-title":"Tumor"},{"key":"key20180107190932_b17-ijo-47-02-0592","first-page":"43","article-title":"The experimental research on cinobufacini inducing apoptosis in human leukemia cell line HL60","volume":"33","author":"Yang","year":"2002","journal-title":"Fujian J Trad Chin Med"},{"key":"key20180107190932_b18-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jep.2010.02.022","article-title":"Cinobufacini, an aqueous extract from Bufo bufo gargarizans Cantor, induces apoptosis through a mitochondria-mediated pathway in human hepatocellular carcinoma cells","volume":"128","author":"Qi","year":"2010","journal-title":"J Ethnopharmacol"},{"key":"key20180107190932_b19-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"key20180107190932_b20-ijo-47-02-0592","first-page":"864","article-title":"Study the effect of antiangiogenesis of arsenic trioxide in combination with cinobufacini on chick embryo choriallantoic membrane","volume":"11","author":"Wang","year":"2006","journal-title":"Chin Clin Oncol"},{"key":"key20180107190932_b21-ijo-47-02-0592","first-page":"89","article-title":"Clinical observation of huachansu injection combined with CHOP regimen in treatment of NHL","volume":"31","author":"Tao","year":"2010","journal-title":"J Med Forum"},{"key":"key20180107190932_b22-ijo-47-02-0592","first-page":"175","article-title":"Effect of Huachansu injection on T-lymphocyte subgroups and natural killer cells in patients with non-Hodgkin lymphoma","volume":"37","author":"Zheng","year":"2010","journal-title":"Liaoning Trad Chin Med"},{"key":"key20180107190932_b23-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1182\/blood-2002-11-3507","article-title":"MEK\/ERK pathway is aberrantly active in Hodgkin disease: A signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival","volume":"102","author":"Zheng","year":"2003","journal-title":"Blood"},{"key":"key20180107190932_b24-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3748\/wjg.v13.i24.3374","article-title":"Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice","volume":"13","author":"Han","year":"2007","journal-title":"World J Gastroenterol"},{"key":"key20180107190932_b25-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.toxicon.2008.05.008","article-title":"Antileishmanial and antitrypanosomal activity of bufadienolides isolated from the toad Rhinella jimi parotoid macrogland secretion","volume":"52","author":"Tempone","year":"2008","journal-title":"Toxicon"},{"key":"key20180107190932_b26-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.toxicon.2005.01.017","article-title":"Antimicrobial activity of the bufadienolides marinobufagin and telocinobufagin isolated as major components from skin secretion of the toad Bufo rubescens","volume":"45","author":"Cunha Filho","year":"2005","journal-title":"Toxicon"},{"key":"key20180107190932_b27-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0031-9422(01)00070-X","article-title":"Ecdysteroids and bufadienolides from Helleborus torquatus (Ranunculaceae)","volume":"57","author":"Meng","year":"2001","journal-title":"Phytochemistry"},{"key":"key20180107190932_b28-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s002800050046","article-title":"Ara-C affects formation of cancer cell DNA synthesome replication intermediates","volume":"45","author":"Abdel-Aziz","year":"2000","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107190932_b29-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1517\/17425247.4.2.175","article-title":"Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chloro-toxin (TM-601)","volume":"4","author":"Mamelak","year":"2007","journal-title":"Expert Opin Drug Deliv"},{"key":"key20180107190932_b30-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1634\/theoncologist.10-10-827","article-title":"ET-743: A novel agent with activity in soft tissue sarcomas","volume":"10","author":"Fayette","year":"2005","journal-title":"Oncologist"},{"key":"key20180107190932_b31-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0959-8049(00)00357-9","article-title":"Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action","volume":"37","author":"Erba","year":"2001","journal-title":"Eur J Cancer"},{"key":"key20180107190932_b32-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1038\/sj.bjc.6601431","article-title":"In vitro interaction between ecteinascidin 743 (ET-743) and radiation, in relation to its cell cycle effects","volume":"89","author":"Simoens","year":"2003","journal-title":"Br J Cancer"},{"key":"key20180107190932_b33-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1021\/np040031y","article-title":"Marine natural products and related compounds in clinical and advanced preclinical trials","volume":"67","author":"Newman","year":"2004","journal-title":"J Nat Prod"},{"key":"key20180107190932_b34-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/modpathol.2012.211","article-title":"Differential expression of aurora-A kinase in T-cell lymphomas","volume":"26","author":"Kanagal-Shamanna","year":"2013","journal-title":"Mod Pathol"},{"key":"key20180107190932_b35-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.exphem.2011.01.013","article-title":"Upregulation of mdr1 gene is related to activation of the MAPK\/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma","volume":"39","author":"Shen","year":"2011","journal-title":"Exp Hematol"},{"key":"key20180107190932_b36-ijo-47-02-0592","first-page":"3961","article-title":"Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: Preparation, cellular uptake, tissue distribution, and anticancer activity","volume":"7","author":"Yin","year":"2012","journal-title":"Int J Nanomed"},{"key":"key20180107190932_b37-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ceb.2003.10.009","article-title":"Mechanisms of caspase activation","volume":"15","author":"Boatright","year":"2003","journal-title":"Curr Opin Cell Biol"},{"key":"key20180107190932_b38-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1146\/annurev.immunol.17.1.781","article-title":"The central effectors of cell death in the immune system","volume":"17","author":"Rathmell","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"key20180107190932_b39-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.fct.2011.10.040","article-title":"Induction of apoptosis by cinobufacini preparation through mitochondria- and Fas-mediated caspase-dependent pathways in human hepatocellular carcinoma cells","volume":"50","author":"Qi","year":"2012","journal-title":"Food Chem Toxicol"},{"key":"key20180107190932_b40-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1478-811X-10-43","article-title":"Global gene expression changes of in vitro stimulated human transformed germinal centre B cells as surrogate for oncogenic pathway activation in individual aggressive B cell lymphomas","volume":"10","author":"Schrader","year":"2012","journal-title":"Cell Commun Signal"},{"key":"key20180107190932_b41-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/gcc.20856","article-title":"Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin\u2019s lymphoma","volume":"50","author":"Green","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"key20180107190932_b42-ijo-47-02-0592","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10616-010-9310-0","article-title":"Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action","volume":"62","author":"Jiang","year":"2010","journal-title":"Cytotechnology"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2015.3044\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T19:13:43Z","timestamp":1515352423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2015.3044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,11]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,6,11]]},"published-print":{"date-parts":[[2015,8]]}},"alternative-id":["10.3892\/ijo.2015.3044"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2015.3044","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,11]]}}}